Back

Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (<70mg/dl): data from CPACS studies

30 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 6 - Adjunctive medical therapy in coronary artery disease Adjunctive medical therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Yihong Sun

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)

26 More presentations in this session

Presentation thumbnail
Doctor T. Nozue (Yokohama, JP)
Abstract
Presentation thumbnail
Presentation thumbnail
Doctor V. Gritti (Cinisello Balsamo, IT)
Abstract Slides
Presentation thumbnail
Professor M. Kim (Gwangju, KR)
Abstract Slides
Presentation thumbnail
Doctor M. Li (Osaka, JP)
Abstract

Access the full session

Session thumbnail
Poster session 6 - Adjunctive medical therapy in coronary artery disease

The Event

Event poster

ESC Congress 2016

30 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Does early initiation of non-statin therapy, evolocumab with LDL-C <50mg/dL contribute to the reduction of hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE
4 April 2025
thumbnail
Congress Presentation
Association of LDL cholesterol levels and all cause mortality in a real world analysis using data from an international network
28 August 2023
thumbnail
Congress Presentation
Addressing the gap: LDL cholesterol control in high-risk patients with acute chest pain in a reference cardiology hospital in brazil
15 March 2025
thumbnail
Congress Presentation
Impact of lipoprotein(a) as a residual risk on long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statin
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources